Top Key Companies for Montelukast Sodium Preparations Market: Morepen Laboratories, Mylan, Teva Pharmaceuticals, Merck, Sandoz, Aurobindo Pharma, Otsuka Pharmaceutical, Yangtze River Pharmaceutical (Group) Co., Ltd., Beijing Winsunny Pharmaceutical Co., Ltd., Nanjing Hicin Pharmaceutical Co.,Ltd., Zhejiang NuoDe Pharmaceutical Co.， Ltd., Hefei Yingtai Pharmaceutical Co., Ltd., Lunan Better Pharmaceutical Co., Ltd., Qilu Pharmaceutical, CSPC Pharmaceutical Group Limited.
Global Montelukast Sodium Preparations Market Size was estimated at USD 5359.9 million in 2022 and is projected to reach USD 10238.44 million by 2028, exhibiting a CAGR of 11.39% during the forecast period.
Global Montelukast Sodium Preparations Market Overview And Scope:
The Global Montelukast Sodium Preparations Market Report 2025 provides comprehensive analysis of market development components, patterns, flows, and sizes. This research study of Montelukast Sodium Preparations utilized both primary and secondary data sources to calculate present and past market values to forecast potential market management for the forecast period between 2025 and 2032. It includes the study of a wide range of industry parameters, including government policies, market environments, competitive landscape, historical data, current market trends, technological innovations, upcoming technologies, and technological progress within related industries. Additionally, the report provides an in-depth analysis of the value chain and supply chain to demonstrate how value is added at every stage in the product lifecycle. The study incorporates market dynamics such as drivers, restraints/challenges, trends, and their impact on the market.
This Market Research Report provides a comprehensive analysis of the global Montelukast Sodium Preparations Market and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Montelukast Sodium Preparations portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Montelukast Sodium Preparations market.
Global Montelukast Sodium Preparations Market Segmentation
By Type, Montelukast Sodium Preparations market has been segmented into:
Chewable Tablets
Regular Tablet
Particles
By Application, Montelukast Sodium Preparations market has been segmented into:
Hospital
Clinic
Other
Regional Analysis of Montelukast Sodium Preparations Market:
North America (U.S., Canada, Mexico)
Eastern Europe (Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe)
Western Europe (Germany, UK, France, Netherlands, Italy, Russia, Spain, Rest of Western Europe)
Asia-Pacific (China, India, Japan, Singapore, Australia, New Zealand, Rest of APAC)
South America (Brazil, Argentina, Rest of SA)
Middle East & Africa (Turkey, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa)
Competitive Landscape of Montelukast Sodium Preparations Market:
Competitive analysis is the study of strength and weakness, market investment, market share, market sales volume, market trends of major players in the market.The Montelukast Sodium Preparations market study focused on including all the primary level, secondary level and tertiary level competitors in the report.The data generated by conducting the primary and secondary research. The report covers detail analysis of driver, constraints and scope for new players entering the Montelukast Sodium Preparations market.
Top Key Companies Covered in Montelukast Sodium Preparations market are:
Morepen Laboratories
Mylan
Teva Pharmaceuticals
Merck
Sandoz
Aurobindo Pharma
Otsuka Pharmaceutical
Yangtze River Pharmaceutical (Group) Co.
Ltd.
Beijing Winsunny Pharmaceutical Co.
Ltd.
Nanjing Hicin Pharmaceutical Co.
Ltd.
Zhejiang NuoDe Pharmaceutical Co.， Ltd.
Hefei Yingtai Pharmaceutical Co.
Ltd.
Lunan Better Pharmaceutical Co.
Ltd.
Qilu Pharmaceutical
CSPC Pharmaceutical Group Limited
Chapter 1: Introduction
1.1 Research Objectives
1.2 Research Methodology
1.3 Research Process
1.4 Scope and Coverage
1.4.1 Market Definition
1.4.2 Key Questions Answered
1.5 Market Segmentation
Chapter 2:Executive Summary
Chapter 3:Growth Opportunities By Segment
3.1 By Type
3.2 By Application
Chapter 4: Market Landscape
4.1 Porter's Five Forces Analysis
4.1.1 Bargaining Power of Supplier
4.1.2 Threat of New Entrants
4.1.3 Threat of Substitutes
4.1.4 Competitive Rivalry
4.1.5 Bargaining Power Among Buyers
4.2 Industry Value Chain Analysis
4.3 Market Dynamics
4.3.1 Drivers
4.3.2 Restraints
4.3.3 Opportunities
4.5.4 Challenges
4.4 Pestle Analysis
4.5 Technological Roadmap
4.6 Regulatory Landscape
4.7 SWOT Analysis
4.8 Price Trend Analysis
4.9 Patent Analysis
4.10 Analysis of the Impact of Covid-19
4.10.1 Impact on the Overall Market
4.10.2 Impact on the Supply Chain
4.10.3 Impact on the Key Manufacturers
4.10.4 Impact on the Pricing
Chapter 5: Montelukast Sodium Preparations Market by Type
5.1 Montelukast Sodium Preparations Market Overview Snapshot and Growth Engine
5.2 Montelukast Sodium Preparations Market Overview
5.3 Chewable Tablets
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Chewable Tablets: Geographic Segmentation
5.4 Regular Tablet
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Regular Tablet: Geographic Segmentation
5.5 Particles
5.5.1 Introduction and Market Overview
5.5.2 Historic and Forecasted Market Size (2017-2032F)
5.5.3 Key Market Trends, Growth Factors and Opportunities
5.5.4 Particles: Geographic Segmentation
Chapter 6: Montelukast Sodium Preparations Market by Application
6.1 Montelukast Sodium Preparations Market Overview Snapshot and Growth Engine
6.2 Montelukast Sodium Preparations Market Overview
6.3 Hospital
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Hospital: Geographic Segmentation
6.4 Clinic
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Clinic: Geographic Segmentation
6.5 Other
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Other: Geographic Segmentation
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Positioning
7.1.2 Montelukast Sodium Preparations Sales and Market Share By Players
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Montelukast Sodium Preparations Industry Concentration Ratio (CR5 and HHI)
7.1.6 Top 5 Montelukast Sodium Preparations Players Market Share
7.1.7 Mergers and Acquisitions
7.1.8 Business Strategies By Top Players
7.2 MOREPEN LABORATORIES
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Operating Business Segments
7.2.5 Product Portfolio
7.2.6 Business Performance
7.2.7 Key Strategic Moves and Recent Developments
7.2.8 SWOT Analysis
7.3 MYLAN
7.4 TEVA PHARMACEUTICALS
7.5 MERCK
7.6 SANDOZ
7.7 AUROBINDO PHARMA
7.8 OTSUKA PHARMACEUTICAL
7.9 YANGTZE RIVER PHARMACEUTICAL (GROUP) CO.
7.10 LTD.
7.11 BEIJING WINSUNNY PHARMACEUTICAL CO.
7.12 LTD.
7.13 NANJING HICIN PHARMACEUTICAL CO.
7.14 LTD.
7.15 ZHEJIANG NUODE PHARMACEUTICAL CO.， LTD.
7.16 HEFEI YINGTAI PHARMACEUTICAL CO.
7.17 LTD.
7.18 LUNAN BETTER PHARMACEUTICAL CO.
7.19 LTD.
7.20 QILU PHARMACEUTICAL
7.21 CSPC PHARMACEUTICAL GROUP LIMITED
Chapter 8: Global Montelukast Sodium Preparations Market Analysis, Insights and Forecast, 2017-2032
8.1 Market Overview
8.2 Historic and Forecasted Market Size By Type
8.2.1 Chewable Tablets
8.2.2 Regular Tablet
8.2.3 Particles
8.3 Historic and Forecasted Market Size By Application
8.3.1 Hospital
8.3.2 Clinic
8.3.3 Other
Chapter 9: North America Montelukast Sodium Preparations Market Analysis, Insights and Forecast, 2017-2032
9.1 Key Market Trends, Growth Factors and Opportunities
9.2 Impact of Covid-19
9.3 Key Players
9.4 Key Market Trends, Growth Factors and Opportunities
9.4 Historic and Forecasted Market Size By Type
9.4.1 Chewable Tablets
9.4.2 Regular Tablet
9.4.3 Particles
9.5 Historic and Forecasted Market Size By Application
9.5.1 Hospital
9.5.2 Clinic
9.5.3 Other
9.6 Historic and Forecast Market Size by Country
9.6.1 US
9.6.2 Canada
9.6.3 Mexico
Chapter 10: Eastern Europe Montelukast Sodium Preparations Market Analysis, Insights and Forecast, 2017-2032
10.1 Key Market Trends, Growth Factors and Opportunities
10.2 Impact of Covid-19
10.3 Key Players
10.4 Key Market Trends, Growth Factors and Opportunities
10.4 Historic and Forecasted Market Size By Type
10.4.1 Chewable Tablets
10.4.2 Regular Tablet
10.4.3 Particles
10.5 Historic and Forecasted Market Size By Application
10.5.1 Hospital
10.5.2 Clinic
10.5.3 Other
10.6 Historic and Forecast Market Size by Country
10.6.1 Bulgaria
10.6.2 The Czech Republic
10.6.3 Hungary
10.6.4 Poland
10.6.5 Romania
10.6.6 Rest of Eastern Europe
Chapter 11: Western Europe Montelukast Sodium Preparations Market Analysis, Insights and Forecast, 2017-2032
11.1 Key Market Trends, Growth Factors and Opportunities
11.2 Impact of Covid-19
11.3 Key Players
11.4 Key Market Trends, Growth Factors and Opportunities
11.4 Historic and Forecasted Market Size By Type
11.4.1 Chewable Tablets
11.4.2 Regular Tablet
11.4.3 Particles
11.5 Historic and Forecasted Market Size By Application
11.5.1 Hospital
11.5.2 Clinic
11.5.3 Other
11.6 Historic and Forecast Market Size by Country
11.6.1 Germany
11.6.2 UK
11.6.3 France
11.6.4 Netherlands
11.6.5 Italy
11.6.6 Russia
11.6.7 Spain
11.6.8 Rest of Western Europe
Chapter 12: Asia Pacific Montelukast Sodium Preparations Market Analysis, Insights and Forecast, 2017-2032
12.1 Key Market Trends, Growth Factors and Opportunities
12.2 Impact of Covid-19
12.3 Key Players
12.4 Key Market Trends, Growth Factors and Opportunities
12.4 Historic and Forecasted Market Size By Type
12.4.1 Chewable Tablets
12.4.2 Regular Tablet
12.4.3 Particles
12.5 Historic and Forecasted Market Size By Application
12.5.1 Hospital
12.5.2 Clinic
12.5.3 Other
12.6 Historic and Forecast Market Size by Country
12.6.1 China
12.6.2 India
12.6.3 Japan
12.6.4 South Korea
12.6.5 Malaysia
12.6.6 Thailand
12.6.7 Vietnam
12.6.8 The Philippines
12.6.9 Australia
12.6.10 New Zealand
12.6.11 Rest of APAC
Chapter 13: Middle East & Africa Montelukast Sodium Preparations Market Analysis, Insights and Forecast, 2017-2032
13.1 Key Market Trends, Growth Factors and Opportunities
13.2 Impact of Covid-19
13.3 Key Players
13.4 Key Market Trends, Growth Factors and Opportunities
13.4 Historic and Forecasted Market Size By Type
13.4.1 Chewable Tablets
13.4.2 Regular Tablet
13.4.3 Particles
13.5 Historic and Forecasted Market Size By Application
13.5.1 Hospital
13.5.2 Clinic
13.5.3 Other
13.6 Historic and Forecast Market Size by Country
13.6.1 Turkey
13.6.2 Bahrain
13.6.3 Kuwait
13.6.4 Saudi Arabia
13.6.5 Qatar
13.6.6 UAE
13.6.7 Israel
13.6.8 South Africa
Chapter 14: South America Montelukast Sodium Preparations Market Analysis, Insights and Forecast, 2017-2032
14.1 Key Market Trends, Growth Factors and Opportunities
14.2 Impact of Covid-19
14.3 Key Players
14.4 Key Market Trends, Growth Factors and Opportunities
14.4 Historic and Forecasted Market Size By Type
14.4.1 Chewable Tablets
14.4.2 Regular Tablet
14.4.3 Particles
14.5 Historic and Forecasted Market Size By Application
14.5.1 Hospital
14.5.2 Clinic
14.5.3 Other
14.6 Historic and Forecast Market Size by Country
14.6.1 Brazil
14.6.2 Argentina
14.6.3 Rest of SA
Chapter 15 Investment Analysis
Chapter 16 Analyst Viewpoint and Conclusion
Montelukast Sodium Preparations Scope:
|
Report Data
|
Montelukast Sodium Preparations Market
|
|
Montelukast Sodium Preparations Market Size in 2025
|
USD XX million
|
|
Montelukast Sodium Preparations CAGR 2025 - 2032
|
XX%
|
|
Montelukast Sodium Preparations Base Year
|
2024
|
|
Montelukast Sodium Preparations Forecast Data
|
2025 - 2032
|
|
Segments Covered
|
By Type, By Application, And by Regions
|
|
Regional Scope
|
North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
|
|
Key Companies Profiled
|
Morepen Laboratories, Mylan, Teva Pharmaceuticals, Merck, Sandoz, Aurobindo Pharma, Otsuka Pharmaceutical, Yangtze River Pharmaceutical (Group) Co., Ltd., Beijing Winsunny Pharmaceutical Co., Ltd., Nanjing Hicin Pharmaceutical Co.,Ltd., Zhejiang NuoDe Pharmaceutical Co.， Ltd., Hefei Yingtai Pharmaceutical Co., Ltd., Lunan Better Pharmaceutical Co., Ltd., Qilu Pharmaceutical, CSPC Pharmaceutical Group Limited.
|
|
Key Segments
|
By Type
Chewable Tablets
Regular Tablet
Particles
By Applications
Hospital
Clinic
Other
|
